We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+6.96%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$342M
AUM Growth
+$51.1M
(+18%)
Cap. Flow
+$47.6M
Cap. Flow
% of AUM
13.91%
Top 10 Holdings %
Top 10 Hldgs %
10.44%
Holding
675
New
141
Increased
130
Reduced
57
Closed
344
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$4.02M |
| 2 |
Nike
NKE
|
+$3.8M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$3.69M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$3.63M |
| 5 |
Costco
COST
|
+$3.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PNC Financial Services
PNC
|
+$3.04M |
| 2 |
Visa
V
|
+$2.98M |
| 3 |
Procter & Gamble
PG
|
+$2.96M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$2.94M |
| 5 |
CPGX
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
|
+$2.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.97% |
| 2 | Industrials | 12.49% |
| 3 | Consumer Discretionary | 11.9% |
| 4 | Healthcare | 11.63% |
| 5 | Consumer Staples | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RAD
126
DELISTED
Rite Aid Corporation
RAD
| $1.01M | 0.3% |
6,585
+6,285
| +2,095% | +$938K |
|
127
Air Products & Chemicals
APD
$65.2B
| $1.01M | 0.29% |
+7,846
| New | +$1.09M |
|
|
TMX
128
DELISTED
Terminix Global Holdings, Inc.
TMX
| $997K | 0.29% |
44,193
-21,499
| -33% | -$541K |
|
129
Dick's Sporting Goods
DKS
$18.9B
| $994K | 0.29% |
17,523
+16,500
| +1,613% | +$908K |
|
|
PF
130
DELISTED
Pinnacle Foods, Inc.
PF
| $981K | 0.29% |
19,548
+3,900
| +25% | +$193K |
|
|
NBIS
131
Nebius Group N.V.
NBIS
$43.1B
| $976K | 0.29% |
+46,365
| New | +$1.01M |
|
|
ARRS
132
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $975K | 0.28% |
34,400
+5,700
| +20% | +$152K |
|
133
Huntington Ingalls Industries
HII
$11.8B
| $967K | 0.28% |
+6,300
| New | +$1.05M |
|
134
Carnival Corporation Ltd
CCL
$38.7B
| $956K | 0.28% |
19,576
-16,000
| -45% | -$740K |
|
|
JOYY
135
JOYY Inc
JOYY
$3.77B
| $949K | 0.28% |
17,805
+17,800
| +356,000% | +$813K |
|
|
CMA
136
DELISTED
Comerica
CMA
| $948K | 0.28% |
+20,036
| New | +$908K |
|
137
Capri Holdings
CPRI
$1.88B
| $945K | 0.28% |
+20,195
| New | +$1.01M |
|
138
Avnet
AVT
$7.07B
| $939K | 0.27% |
22,875
+21,000
| +1,120% | +$856K |
|
139
S&P Global
SPGI
$126B
| $937K | 0.27% |
+7,400
| New | +$889K |
|
|
CTRA
140
DELISTED
Coterra Energy
CTRA
| $936K | 0.27% |
+36,297
| New | +$908K |
|
141
Kraft Heinz
KHC
$32.4B
| $931K | 0.27% |
10,400
+1,800
| +21% | +$159K |
|
142
Casey's General Stores
CASY
$31.7B
| $925K | 0.27% |
+7,700
| New | +$991K |
|
143
Charter Communications
CHTR
$16.7B
| $918K | 0.27% |
+3,400
| New | +$859K |
|
144
NCR Voyix
VYX
$1.19B
| $902K | 0.26% |
45,692
+5,379
| +13% | +$106K |
|
145
Golar LNG
GLNG
$4.95B
| $886K | 0.26% |
+41,807
| New | +$799K |
|
|
PDCE
146
DELISTED
PDC Energy, Inc.
PDCE
| $884K | 0.26% |
+13,181
| New | +$798K |
|
|
HZNP
147
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $883K | 0.26% |
+48,694
| New | +$951K |
|
|
APC
148
DELISTED
Anadarko Petroleum
APC
| $878K | 0.26% |
+13,855
| New | +$772K |
|
149
Weibo
WB
$1.95B
| $857K | 0.25% |
+17,101
| New | +$707K |
|
150
Goodyear
GT
$2.12B
| $836K | 0.24% |
25,895
+25,400
| +5,131% | +$739K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q3 2016 Portfolio in Review
As of Q3 2016, Seven Eight Capital held 675 positions worth $342M, up 18% from $291M the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Seven Eight Capital deployed $47.6M of net new capital in Q3 2016, opening 141 new positions and adding to 130 existing holdings. Its largest new stake was Teva Pharmaceuticals: 77,100 shares worth $3.55M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Mastercard, an estimated $2.55M trimmed.
- Seven Eight Capital's largest Q3 2016 buy was Teva Pharmaceuticals: 77,100 shares worth $3.55M.
- Seven Eight Capital added most to Bristol-Myers Squibb in Q3 2016, an estimated $3.69M increase.
- Seven Eight Capital's biggest Q3 2016 reduction was Mastercard, cutting an estimated $2.55M.
- Seven Eight Capital fully exited PNC Financial Services in Q3 2016, selling an estimated $3.04M.
- Seven Eight Capital's ten largest holdings make up 10% of its $342M portfolio in Q3 2016.
- Seven Eight Capital opened 141 new positions and closed 344 in Q3 2016.
- Seven Eight Capital's portfolio value rose 18% quarter-over-quarter to $342M.
Based on Seven Eight Capital's 13F filing for Q3 2016, filed 14 Nov 2016.